Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
1,582,162
-
Total 13F shares
-
3,151,890
-
Share change
-
-11,497
-
Total reported value
-
$1,667,349
-
Price per share
-
$0.53
-
Number of holders
-
15
-
Value change
-
-$8,058
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of Evoke Pharma, Inc. - Common Shares (EVOK) as of Q2 2024
As of 30 Jun 2024,
Evoke Pharma, Inc. - Common Shares (EVOK) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,151,890 shares.
The largest 10 holders included
AIGH Capital Management LLC, Bleichroeder LP, Altium Capital Management LP, Nantahala Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, STATE STREET CORP, Tower Research Capital LLC (TRC), and BlackRock Inc..
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.